Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | NPY1R | P25929 | 1/20 | 0.32 |
| ▸ | NPY2R | P49146 | 1/20 | 0.32 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.31 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | RAD52 | P43351 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11248014 | 0.77 | CYP2C19 (0.35) | TSHRNPY1RNPY2RPLA2G1BPLA2G2A | |
| SCHEMBL25178946 | 0.77 | CETP (0.40) | TSHRNPY1RNPY2RPLA2G1BPLA2G2A | |
| SCHEMBL11996520 | 0.77 | TSHR (0.48) | TSHR | |
| SCHEMBL19061169 | 0.75 | LMNA (0.35) | TSHRL3MBTL1 | |
| SCHEMBL16597197 | 0.74 | PLA2G1B (0.37) | TSHRNPY1RNPY2RPLA2G1BPLA2G2A | |
| SCHEMBL20243280 | 0.73 | TSHR (0.44) | TSHR | |
| SCHEMBL12891039 | 0.72 | TSHR (0.48) | TSHRALDH1A1CYP2D6 | |
| SCHEMBL12712359 | 0.72 | TSHR (0.48) | TSHRALDH1A1CYP2D6 | |
| SCHEMBL14279092 | 0.72 | PLA2G1B (0.33) | PLA2G1BPLA2G2A | |
| SCHEMBL12712358 | 0.72 | TSHR (0.48) | TSHRALDH1A1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9994593-B2 | Copper compound, starting material for forming thin film, and method for manufacturing thin film | ADEKA CORPORATION (JP) | 2018-06-12 | — | — | US | disclosed |
| EP-3144313-A1 | COBALT COMPOUND, RAW MATERIAL FOR FORMING THIN FILM, AND METHOD FOR PRODUCING THIN FILM | Adeka Corporation (JP) | 2017-03-22 | — | — | EP | disclosed |
| US-20170050998-A1 | COBALT COMPOUND, THIN FILM-FORMING RAW MATERIAL, AND METHOD FOR PRODUCING THIN FILM | ADEKA CORPORATION (JP) | 2017-02-23 | — | — | US | disclosed |
| EP-0563557-B1 | Volatile rate earth metal alkoxides, especially for the preparation of rare earth metal oxides, and alcohols for the synthesis of volatile compounds | PATENT TREUHAND GES FUER ELEKTRISCHE GLUEHLAMPEN MBH (DE) | 1998-08-12 | — | — | EP | disclosed |
| EP-0563557-A2 | Volatile rate earth metal alkoxides, especially for the preparation of rare earth metal oxides, and alcohols for the synthesis of volatile compounds | Patent-Treuhand-Gesellschaft für elektrische Glühlampen mbH (DE) | 1993-10-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170050998-A1 | COBALT COMPOUND, THIN FILM-FORMING RAW MATERIAL, AND METHOD FOR PRODUCING THIN FILM | C5, C9, TFRC | TSHR 4507/4885NPY1R 2749/4885NPY2R 3062/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.